Robert G. Mealer

Robert G. Mealer

Auto-generated profile, based on publicly available information

Robert G. Mealer

Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
SWSarah E. Williams
Sarah E. Williams
MNMaxence Noel
Maxence Noel
SLSylvain Lehoux
Sylvain Lehoux
MCMurat Cetinbas
Murat Cetinbas
RXRamnik J. Xavier
Ramnik J. Xavier
RMRobert G. Mealer
Robert G. Mealer
Glycosylation is essential to brain development and function, but prior studies have often been limited to a single analytical technique and excluded region- and sex-specific analyses. Here, using several methodologies, we analyze Asn-linked and Ser/Thr/Tyr-linked protein glycosylation between brain regions and sexes in mice. Brain N-glycans are less complex in sequence and variety compared to other tissues, consisting predominantly of high-mannose and fucosylated/bisected structures. Most brain O-glycans are unbranched, sialylated O-GalNAc and O-mannose structures. A consistent pattern is observed between regions, and sex differences are minimal compared to those in plasma. Brain glycans correlate with RNA expression of their synthetic enzymes, and analysis of glycosylation genes in humans show a global downregulation in the brain compared to other tissues. We hypothesize that this restricted repertoire of protein glycans arises from their tight regulation in the brain. These results provide a roadmap for future studies of glycosylation in neurodevelopment and disease.

4 August 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RMRobert G. Mealer
Robert G. Mealer
BJBruce G. Jenkins
Bruce G. Jenkins
CCChia-Yen Chen
Chia-Yen Chen
MDMark J. Daly
Mark J. Daly
TGTian Ge
Tian Ge
JSJordan Smoller
Jordan Smoller
A common missense variant in SLC39A8 is convincingly associated with schizophrenia and several additional phenotypes. Homozygous loss-of-function mutations in SLC39A8 result in undetectable serum manganese (Mn) and a Congenital Disorder of Glycosylation (CDG) due to the exquisite sensitivity of glycosyltransferases to Mn concentration. Here, we identified several Mn-related changes in human carriers of the common SLC39A8 missense allele. Analysis of structural brain MRI scans showed a dose-dependent change in the ratio of T2w to T1w signal in several regions. Comprehensive trace element analysis confirmed a specific reduction of only serum Mn, and plasma protein N-glycome profiling revealed reduced complexity and branching. N-glycome profiling from two individuals with SLC39A8-CDG showed similar but more severe alterations in branching that improved with Mn supplementation, suggesting that the common variant exists on a spectrum of hypofunction with potential for reversibility. Characterizing the functional impact of this variant will enhance our understanding of schizophrenia pathogenesis and identify novel therapeutic targets and biomarkers.

6 May 2020 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
RMRobert G. Mealer
Robert G. Mealer
SWSarah Williams
Sarah Williams
MDMark J. Daly
Mark J. Daly
ESEdward M. Scolnick
Edward M. Scolnick
RCRichard D. Cummings
Richard D. Cummings
JSJordan W. Smoller
Jordan W. Smoller

13 May 2020 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
SWSarah Williams
Sarah Williams
RMRobert G. Mealer
Robert G. Mealer
ESEdward M. Scolnick
Edward M. Scolnick
JSJordan W. Smoller
Jordan W. Smoller
RCRichard D. Cummings
Richard D. Cummings

27 October 2022 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
SSSuttipong Suttapitugsakul
Suttipong Suttapitugsakul
KSKathrin Stavenhagen
Kathrin Stavenhagen
SDSofia Donskaya
Sofia Donskaya
DBDavid A. Bennett
David A. Bennett
RMRobert G. Mealer
Robert G. Mealer
Richard D. CummingsRichard D. Cummings
Richard D. Cummings
Molecular changes in the brain of individuals afflicted with Alzheimer's disease (AD) are an intense area of study. Little is known about the role of protein abundance and posttranslational modifications in AD progression and treatment, in particular large-scale intact N-linked glycoproteomics analysis. To elucidate the N-glycoproteome landscape, we developed an approach based on multi-lectin affinity enrichment, hydrophilic interaction chromatography, and LC-MS–based glycoproteomics. We analyzed brain tissue from 10 persons with no cognitive impairment or AD, 10 with asymptomatic AD, and 10 with symptomatic AD, detecting over 300 glycoproteins and 1900 glycoforms across the samples. The majority of glycoproteins have N-glycans that are high-mannosidic or complex chains that are fucosylated and bisected. The Man5 N-glycan was found to occur most frequently at >20% of the total glycoforms. Unlike the glycoproteomes of other tissues, sialylation is a minor feature of the brain N-glycoproteome, occurring at <9% among the glycoforms. We observed AD-associated differences in the number of antennae, frequency of fucosylation, bisection, and other monosaccharides at individual glycosylation sites among samples from our three groups. Further analysis revealed glycosylation differences in subcellular compartments across disease stage, including glycoproteins in the lysosome frequently modified with paucimannosidic glycans. These results illustrate the N-glycoproteomics landscape across the spectrum of AD clinical and pathologic severity and will facilitate a deeper understanding of progression and treatment development.

8 March 2022 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
RMRobert G. Mealer
Robert G. Mealer
SWSarah Williams
Sarah Williams
MNMaxence Noel
Maxence Noel
BYBo Yang
Bo Yang
ADAlexandria K. D’souza
Alexandria K. D’souza
Richard D. CummingsRichard D. Cummings
Richard D. Cummings